0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NAD+ Anti-aging Intravenous Injection Therapy Market Research Report 2025
Published Date: November 2025
|
Report Code: QYRE-Auto-7W20281
Home | Market Reports | Health| Pharmacy
Global NAD Anti aging Intravenous Injection Therapy Market Research Report 2025
BUY CHAPTERS

Global NAD+ Anti-aging Intravenous Injection Therapy Market Research Report 2025

Code: QYRE-Auto-7W20281
Report
November 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

NAD+ Anti-aging Intravenous Injection Therapy Market Size

The global market for NAD+ Anti-aging Intravenous Injection Therapy was valued at US$ 103 million in the year 2024 and is projected to reach a revised size of US$ 154 million by 2031, growing at a CAGR of 5.0% during the forecast period.

NAD+ Anti-aging Intravenous Injection Therapy Market

NAD+ Anti-aging Intravenous Injection Therapy Market

NAD+ Anti-aging Intravenous Injection Therapy is an anti-aging and energy metabolism intervention therapy that delivers nicotinamide adenine dinucleotide (NAD+) directly into the bloodstream via intravenous injection. NAD+ is a key intracellular coenzyme involved in energy production, DNA repair, antioxidation, and metabolic regulation. Through intravenous injection, NAD+ concentrations in the body can be rapidly increased, promoting cell vitality and metabolism, thereby improving fatigue, cognitive function, and sleep quality, and potentially delaying aging and assisting in the treatment of chronic diseases. The upstream mainly involves NAD+ raw material manufacturers, pharmaceutical raw material suppliers, and injectable formulation manufacturers; the downstream targets medical aesthetic institutions, anti-aging clinics, rehabilitation centers, and high-end health management service providers. With the increasing demand for health management and precision medicine, NAD+ intravenous injection therapy is gradually becoming a popular project for high-end anti-aging and functional health interventions.
North American market for NAD+ Anti-aging Intravenous Injection Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NAD+ Anti-aging Intravenous Injection Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for NAD+ Anti-aging Intravenous Injection Therapy in Clinic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of NAD+ Anti-aging Intravenous Injection Therapy include The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NAD+ Anti-aging Intravenous Injection Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NAD+ Anti-aging Intravenous Injection Therapy.
The NAD+ Anti-aging Intravenous Injection Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NAD+ Anti-aging Intravenous Injection Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Period and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NAD+ Anti-aging Intravenous Injection Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of NAD+ Anti-aging Intravenous Injection Therapy Market Report

Report Metric Details
Report Name NAD+ Anti-aging Intravenous Injection Therapy Market
Accounted market size in year US$ 103 million
Forecasted market size in 2031 US$ 154 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • NAD+ Vitamin Mix Injection
  • Pure NAD+ Injection
Segment by Period
  • Single-use Injection Type
  • Recurring Injection Type
  • Other
Segment by Dose
  • Low-dose Type
  • Medium-dose Type
  • High-dose Type
Segment by Application
  • Clinic
  • Hospital
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, Effect Doctors, Nadclinic, Hydrate IV Bar, LIVV Natural, BioReset Medical, IV Boost UK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Period etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of NAD+ Anti-aging Intravenous Injection Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is NAD+ Anti-aging Intravenous Injection Therapy Market growing?

Ans: The NAD+ Anti-aging Intravenous Injection Therapy Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the NAD+ Anti-aging Intravenous Injection Therapy Market size in 2031?

Ans: The NAD+ Anti-aging Intravenous Injection Therapy Market size in 2031 will be US$ 154 million.

Who are the main players in the NAD+ Anti-aging Intravenous Injection Therapy Market report?

Ans: The main players in the NAD+ Anti-aging Intravenous Injection Therapy Market are The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, Effect Doctors, Nadclinic, Hydrate IV Bar, LIVV Natural, BioReset Medical, IV Boost UK

What are the Application segmentation covered in the NAD+ Anti-aging Intravenous Injection Therapy Market report?

Ans: The Applications covered in the NAD+ Anti-aging Intravenous Injection Therapy Market report are Clinic, Hospital, Other

What are the Type segmentation covered in the NAD+ Anti-aging Intravenous Injection Therapy Market report?

Ans: The Types covered in the NAD+ Anti-aging Intravenous Injection Therapy Market report are NAD+ Vitamin Mix Injection, Pure NAD+ Injection

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NAD+ Vitamin Mix Injection
1.2.3 Pure NAD+ Injection
1.3 Market by Period
1.3.1 Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Period: 2020 VS 2024 VS 2031
1.3.2 Single-use Injection Type
1.3.3 Recurring Injection Type
1.3.4 Other
1.4 Market by Dose
1.4.1 Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Dose: 2020 VS 2024 VS 2031
1.4.2 Low-dose Type
1.4.3 Medium-dose Type
1.4.4 High-dose Type
1.5 Market by Application
1.5.1 Global NAD+ Anti-aging Intravenous Injection Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global NAD+ Anti-aging Intravenous Injection Therapy Market Perspective (2020-2031)
2.2 Global NAD+ Anti-aging Intravenous Injection Therapy Growth Trends by Region
2.2.1 Global NAD+ Anti-aging Intravenous Injection Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NAD+ Anti-aging Intravenous Injection Therapy Historic Market Size by Region (2020-2025)
2.2.3 NAD+ Anti-aging Intravenous Injection Therapy Forecasted Market Size by Region (2026-2031)
2.3 NAD+ Anti-aging Intravenous Injection Therapy Market Dynamics
2.3.1 NAD+ Anti-aging Intravenous Injection Therapy Industry Trends
2.3.2 NAD+ Anti-aging Intravenous Injection Therapy Market Drivers
2.3.3 NAD+ Anti-aging Intravenous Injection Therapy Market Challenges
2.3.4 NAD+ Anti-aging Intravenous Injection Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NAD+ Anti-aging Intravenous Injection Therapy Players by Revenue
3.1.1 Global Top NAD+ Anti-aging Intravenous Injection Therapy Players by Revenue (2020-2025)
3.1.2 Global NAD+ Anti-aging Intravenous Injection Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top NAD+ Anti-aging Intravenous Injection Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NAD+ Anti-aging Intravenous Injection Therapy Revenue
3.4 Global NAD+ Anti-aging Intravenous Injection Therapy Market Concentration Ratio
3.4.1 Global NAD+ Anti-aging Intravenous Injection Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NAD+ Anti-aging Intravenous Injection Therapy Revenue in 2024
3.5 Global Key Players of NAD+ Anti-aging Intravenous Injection Therapy Head office and Area Served
3.6 Global Key Players of NAD+ Anti-aging Intravenous Injection Therapy, Product and Application
3.7 Global Key Players of NAD+ Anti-aging Intravenous Injection Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NAD+ Anti-aging Intravenous Injection Therapy Breakdown Data by Type
4.1 Global NAD+ Anti-aging Intravenous Injection Therapy Historic Market Size by Type (2020-2025)
4.2 Global NAD+ Anti-aging Intravenous Injection Therapy Forecasted Market Size by Type (2026-2031)
5 NAD+ Anti-aging Intravenous Injection Therapy Breakdown Data by Application
5.1 Global NAD+ Anti-aging Intravenous Injection Therapy Historic Market Size by Application (2020-2025)
5.2 Global NAD+ Anti-aging Intravenous Injection Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NAD+ Anti-aging Intravenous Injection Therapy Market Size (2020-2031)
6.2 North America NAD+ Anti-aging Intravenous Injection Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025)
6.4 North America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NAD+ Anti-aging Intravenous Injection Therapy Market Size (2020-2031)
7.2 Europe NAD+ Anti-aging Intravenous Injection Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025)
7.4 Europe NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Size (2020-2031)
8.2 Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Size (2020-2031)
9.2 Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025)
9.4 Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Size (2020-2031)
10.2 Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 The Wellness Lab
11.1.1 The Wellness Lab Company Details
11.1.2 The Wellness Lab Business Overview
11.1.3 The Wellness Lab NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.1.4 The Wellness Lab Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.1.5 The Wellness Lab Recent Development
11.2 Conciergemdla
11.2.1 Conciergemdla Company Details
11.2.2 Conciergemdla Business Overview
11.2.3 Conciergemdla NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.2.4 Conciergemdla Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.2.5 Conciergemdla Recent Development
11.3 Azivmedics
11.3.1 Azivmedics Company Details
11.3.2 Azivmedics Business Overview
11.3.3 Azivmedics NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.3.4 Azivmedics Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.3.5 Azivmedics Recent Development
11.4 Reset IV
11.4.1 Reset IV Company Details
11.4.2 Reset IV Business Overview
11.4.3 Reset IV NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.4.4 Reset IV Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.4.5 Reset IV Recent Development
11.5 Thedripclub
11.5.1 Thedripclub Company Details
11.5.2 Thedripclub Business Overview
11.5.3 Thedripclub NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.5.4 Thedripclub Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.5.5 Thedripclub Recent Development
11.6 Toronto Functional Medicine Centre
11.6.1 Toronto Functional Medicine Centre Company Details
11.6.2 Toronto Functional Medicine Centre Business Overview
11.6.3 Toronto Functional Medicine Centre NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.6.4 Toronto Functional Medicine Centre Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.6.5 Toronto Functional Medicine Centre Recent Development
11.7 Mobileivmedics
11.7.1 Mobileivmedics Company Details
11.7.2 Mobileivmedics Business Overview
11.7.3 Mobileivmedics NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.7.4 Mobileivmedics Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.7.5 Mobileivmedics Recent Development
11.8 Rocky Mountain Ivmedics
11.8.1 Rocky Mountain Ivmedics Company Details
11.8.2 Rocky Mountain Ivmedics Business Overview
11.8.3 Rocky Mountain Ivmedics NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.8.4 Rocky Mountain Ivmedics Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.8.5 Rocky Mountain Ivmedics Recent Development
11.9 Seaside Skin Care
11.9.1 Seaside Skin Care Company Details
11.9.2 Seaside Skin Care Business Overview
11.9.3 Seaside Skin Care NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.9.4 Seaside Skin Care Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.9.5 Seaside Skin Care Recent Development
11.10 Premiumhealth
11.10.1 Premiumhealth Company Details
11.10.2 Premiumhealth Business Overview
11.10.3 Premiumhealth NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.10.4 Premiumhealth Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.10.5 Premiumhealth Recent Development
11.11 Effect Doctors
11.11.1 Effect Doctors Company Details
11.11.2 Effect Doctors Business Overview
11.11.3 Effect Doctors NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.11.4 Effect Doctors Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.11.5 Effect Doctors Recent Development
11.12 Nadclinic
11.12.1 Nadclinic Company Details
11.12.2 Nadclinic Business Overview
11.12.3 Nadclinic NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.12.4 Nadclinic Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.12.5 Nadclinic Recent Development
11.13 Hydrate IV Bar
11.13.1 Hydrate IV Bar Company Details
11.13.2 Hydrate IV Bar Business Overview
11.13.3 Hydrate IV Bar NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.13.4 Hydrate IV Bar Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.13.5 Hydrate IV Bar Recent Development
11.14 LIVV Natural
11.14.1 LIVV Natural Company Details
11.14.2 LIVV Natural Business Overview
11.14.3 LIVV Natural NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.14.4 LIVV Natural Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.14.5 LIVV Natural Recent Development
11.15 BioReset Medical
11.15.1 BioReset Medical Company Details
11.15.2 BioReset Medical Business Overview
11.15.3 BioReset Medical NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.15.4 BioReset Medical Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.15.5 BioReset Medical Recent Development
11.16 IV Boost UK
11.16.1 IV Boost UK Company Details
11.16.2 IV Boost UK Business Overview
11.16.3 IV Boost UK NAD+ Anti-aging Intravenous Injection Therapy Introduction
11.16.4 IV Boost UK Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
11.16.5 IV Boost UK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of NAD+ Vitamin Mix Injection
 Table 3. Key Players of Pure NAD+ Injection
 Table 4. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Period (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Key Players of Single-use Injection Type
 Table 6. Key Players of Recurring Injection Type
 Table 7. Key Players of Other
 Table 8. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Dose (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Key Players of Low-dose Type
 Table 10. Key Players of Medium-dose Type
 Table 11. Key Players of High-dose Type
 Table 12. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 13. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 14. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 15. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Region (2020-2025)
 Table 16. Global NAD+ Anti-aging Intravenous Injection Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 17. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Region (2026-2031)
 Table 18. NAD+ Anti-aging Intravenous Injection Therapy Market Trends
 Table 19. NAD+ Anti-aging Intravenous Injection Therapy Market Drivers
 Table 20. NAD+ Anti-aging Intravenous Injection Therapy Market Challenges
 Table 21. NAD+ Anti-aging Intravenous Injection Therapy Market Restraints
 Table 22. Global NAD+ Anti-aging Intravenous Injection Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 23. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Players (2020-2025)
 Table 24. Global Top NAD+ Anti-aging Intravenous Injection Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Anti-aging Intravenous Injection Therapy as of 2024)
 Table 25. Ranking of Global Top NAD+ Anti-aging Intravenous Injection Therapy Companies by Revenue (US$ Million) in 2024
 Table 26. Global 5 Largest Players Market Share by NAD+ Anti-aging Intravenous Injection Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 27. Global Key Players of NAD+ Anti-aging Intravenous Injection Therapy, Headquarters and Area Served
 Table 28. Global Key Players of NAD+ Anti-aging Intravenous Injection Therapy, Product and Application
 Table 29. Global Key Players of NAD+ Anti-aging Intravenous Injection Therapy, Date of Enter into This Industry
 Table 30. Mergers & Acquisitions, Expansion Plans
 Table 31. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 32. Global NAD+ Anti-aging Intravenous Injection Therapy Revenue Market Share by Type (2020-2025)
 Table 33. Global NAD+ Anti-aging Intravenous Injection Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 34. Global NAD+ Anti-aging Intravenous Injection Therapy Revenue Market Share by Type (2026-2031)
 Table 35. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 36. Global NAD+ Anti-aging Intravenous Injection Therapy Revenue Market Share by Application (2020-2025)
 Table 37. Global NAD+ Anti-aging Intravenous Injection Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 38. Global NAD+ Anti-aging Intravenous Injection Therapy Revenue Market Share by Application (2026-2031)
 Table 39. North America NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. North America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. North America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Europe NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Europe NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Europe NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 47. Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 48. Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 52. Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 53. Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 54. The Wellness Lab Company Details
 Table 55. The Wellness Lab Business Overview
 Table 56. The Wellness Lab NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 57. The Wellness Lab Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 58. The Wellness Lab Recent Development
 Table 59. Conciergemdla Company Details
 Table 60. Conciergemdla Business Overview
 Table 61. Conciergemdla NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 62. Conciergemdla Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 63. Conciergemdla Recent Development
 Table 64. Azivmedics Company Details
 Table 65. Azivmedics Business Overview
 Table 66. Azivmedics NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 67. Azivmedics Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 68. Azivmedics Recent Development
 Table 69. Reset IV Company Details
 Table 70. Reset IV Business Overview
 Table 71. Reset IV NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 72. Reset IV Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 73. Reset IV Recent Development
 Table 74. Thedripclub Company Details
 Table 75. Thedripclub Business Overview
 Table 76. Thedripclub NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 77. Thedripclub Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 78. Thedripclub Recent Development
 Table 79. Toronto Functional Medicine Centre Company Details
 Table 80. Toronto Functional Medicine Centre Business Overview
 Table 81. Toronto Functional Medicine Centre NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 82. Toronto Functional Medicine Centre Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 83. Toronto Functional Medicine Centre Recent Development
 Table 84. Mobileivmedics Company Details
 Table 85. Mobileivmedics Business Overview
 Table 86. Mobileivmedics NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 87. Mobileivmedics Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 88. Mobileivmedics Recent Development
 Table 89. Rocky Mountain Ivmedics Company Details
 Table 90. Rocky Mountain Ivmedics Business Overview
 Table 91. Rocky Mountain Ivmedics NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 92. Rocky Mountain Ivmedics Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 93. Rocky Mountain Ivmedics Recent Development
 Table 94. Seaside Skin Care Company Details
 Table 95. Seaside Skin Care Business Overview
 Table 96. Seaside Skin Care NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 97. Seaside Skin Care Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 98. Seaside Skin Care Recent Development
 Table 99. Premiumhealth Company Details
 Table 100. Premiumhealth Business Overview
 Table 101. Premiumhealth NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 102. Premiumhealth Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 103. Premiumhealth Recent Development
 Table 104. Effect Doctors Company Details
 Table 105. Effect Doctors Business Overview
 Table 106. Effect Doctors NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 107. Effect Doctors Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 108. Effect Doctors Recent Development
 Table 109. Nadclinic Company Details
 Table 110. Nadclinic Business Overview
 Table 111. Nadclinic NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 112. Nadclinic Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 113. Nadclinic Recent Development
 Table 114. Hydrate IV Bar Company Details
 Table 115. Hydrate IV Bar Business Overview
 Table 116. Hydrate IV Bar NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 117. Hydrate IV Bar Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 118. Hydrate IV Bar Recent Development
 Table 119. LIVV Natural Company Details
 Table 120. LIVV Natural Business Overview
 Table 121. LIVV Natural NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 122. LIVV Natural Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 123. LIVV Natural Recent Development
 Table 124. BioReset Medical Company Details
 Table 125. BioReset Medical Business Overview
 Table 126. BioReset Medical NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 127. BioReset Medical Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 128. BioReset Medical Recent Development
 Table 129. IV Boost UK Company Details
 Table 130. IV Boost UK Business Overview
 Table 131. IV Boost UK NAD+ Anti-aging Intravenous Injection Therapy Product
 Table 132. IV Boost UK Revenue in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025) & (US$ Million)
 Table 133. IV Boost UK Recent Development
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources
 Table 137. Authors List of This Report


List of Figures
 Figure 1. NAD+ Anti-aging Intravenous Injection Therapy Picture
 Figure 2. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Type: 2024 VS 2031
 Figure 4. NAD+ Vitamin Mix Injection Features
 Figure 5. Pure NAD+ Injection Features
 Figure 6. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Comparison by Period (2020-2031) & (US$ Million)
 Figure 7. Single-use Injection Type Features
 Figure 8. Recurring Injection Type Features
 Figure 9. Other Features
 Figure 10. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size Comparison by Dose (2020-2031) & (US$ Million)
 Figure 11. Low-dose Type Features
 Figure 12. Medium-dose Type Features
 Figure 13. High-dose Type Features
 Figure 14. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 15. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Application: 2024 VS 2031
 Figure 16. Clinic Case Studies
 Figure 17. Hospital Case Studies
 Figure 18. Other Case Studies
 Figure 19. NAD+ Anti-aging Intravenous Injection Therapy Report Years Considered
 Figure 20. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 21. Global NAD+ Anti-aging Intravenous Injection Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 22. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Region: 2024 VS 2031
 Figure 23. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Players in 2024
 Figure 24. Global NAD+ Anti-aging Intravenous Injection Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 25. The Top 10 and 5 Players Market Share by NAD+ Anti-aging Intravenous Injection Therapy Revenue in 2024
 Figure 26. North America NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. North America NAD+ Anti-aging Intravenous Injection Therapy Market Share by Country (2020-2031)
 Figure 28. United States NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Canada NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe NAD+ Anti-aging Intravenous Injection Therapy Market Share by Country (2020-2031)
 Figure 32. Germany NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Ireland NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific NAD+ Anti-aging Intravenous Injection Therapy Market Share by Region (2020-2031)
 Figure 40. China NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Japan NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. India NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Australia & New Zealand NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America NAD+ Anti-aging Intravenous Injection Therapy Market Share by Country (2020-2031)
 Figure 48. Mexico NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Brazil NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa NAD+ Anti-aging Intravenous Injection Therapy Market Share by Country (2020-2031)
 Figure 52. Israel NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. UAE NAD+ Anti-aging Intravenous Injection Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. The Wellness Lab Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 56. Conciergemdla Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 57. Azivmedics Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 58. Reset IV Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 59. Thedripclub Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 60. Toronto Functional Medicine Centre Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 61. Mobileivmedics Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 62. Rocky Mountain Ivmedics Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 63. Seaside Skin Care Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 64. Premiumhealth Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 65. Effect Doctors Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 66. Nadclinic Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 67. Hydrate IV Bar Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 68. LIVV Natural Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 69. BioReset Medical Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 70. IV Boost UK Revenue Growth Rate in NAD+ Anti-aging Intravenous Injection Therapy Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Daridorexant Hydrochloride Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-31P19998
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global NAD+ Intravenous Injection Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12D20155
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global NAD+ Anti-aging Intravenous Injection Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7W20281
Wed Nov 19 00:00:00 UTC 2025

Add to Cart